HIF1A and cancer: Moreover, oroxylin A (PubChem CID: 5320315) treatment has been linked to a reduction in cancer-related glycolysis via sirtuin-3 mediated destabilization of HIF-1 in MDA-MB-231 cells (Wei et al., 2015).